Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows

Camurus

Market Cap: SEK 40.2b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Kuros Biosciences

Market Cap: CHF 1.1b

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

SK Biopharmaceuticals

Market Cap: ₩7.6t

A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.

Niagen Bioscience

Market Cap: US$769.6m

Operates as a bioscience company engages in developing healthy aging products.

Xiamen Amoytop Biotech

Market Cap: CN¥35.1b

Engages in research, development, production, and sale of recombinant protein drugs in China.

Takara Bio

Market Cap: JP¥116.1b

Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.

Ligand Pharmaceuticals

Market Cap: US$3.0b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

Tonghua Dongbao Pharmaceutical

Market Cap: CN¥16.5b

Researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China.

Rhythm Pharmaceuticals

Market Cap: US$6.5b

A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.

Galderma Group

Market Cap: CHF 31.6b

Operates as a dermatology company worldwide.

Eurofins Scientific

Market Cap: €12.2b

Provides various analytical testing and laboratory services worldwide.

BioLife Solutions

Market Cap: US$1.2b

Develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally.

Vitrolife

Market Cap: SEK 18.7b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

BioGaia

Market Cap: SEK 9.6b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

SKAN Group

Market Cap: CHF 1.6b

Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.

Biocon

Market Cap: ₹477.4b

Manufactures and sells biotechnology products and research services in India, the United States, Ireland, rest of the European Union, and internationally.

Zhejiang Jolly PharmaceuticalLTD

Market Cap: CN¥13.7b

Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.

Eli Lilly

Market Cap: US$631.3b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Medical Developments International

Market Cap: AU$69.3m

Manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally.

Trajan Group Holdings

Market Cap: AU$141.7m

Develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India.

Everest Medicines

Market Cap: HK$24.3b

A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.

Shanghai Allist Pharmaceuticals

Market Cap: CN¥40.4b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.

Shanghai OPM Biosciences

Market Cap: CN¥6.4b

Provides cell culture media and CDMO services in China and internationally.

Bonesupport Holding

Market Cap: SEK 19.0b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

Simcere Pharmaceutical Group

Market Cap: HK$31.6b

An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.

Sotera Health

Market Cap: US$4.6b

Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.

RemeGen

Market Cap: HK$46.8b

A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$103.7b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.

Indoco Remedies

Market Cap: ₹25.7b

Manufactures and markets formulations and active pharmaceutical ingredients in India and internationally.

Caris Life Sciences

Market Cap: US$10.4b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

Repligen

Market Cap: US$6.9b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

Laboratorios Farmaceuticos Rovi

Market Cap: €2.9b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

PharmaResearch

Market Cap: ₩7.1t

Operates as a biopharmaceutical company primarily in South Korea.

InnoCare Pharma

Market Cap: HK$37.3b

A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.

Nanjing Vazyme Biotech

Market Cap: CN¥10.1b

Offers technology solutions for life science, biomedicine, and in vitro diagnostics.

Sartorius Stedim Biotech

Market Cap: €17.5b

Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.